Home
overview

The conference listed on this page was held in 2008. For information on the 2010 conference go to www.smi-online.co.uk/2010europricing.asp  

European Pharmaceutical Pricing & Reimbursement Conference 2010

  


 
Today’s climate in the pharmacoeconomic arena, characterized by sinking profit margins, redistributions of market shares and increasing competition, all highlight an urgent need to identify clear strategies for the future of pharmaceutical pricing and reimbursement. SMi is proud to present its 14th Annual European Pharmaceutical Pricing and Reimbursement Conference, which will bring together the leading figures in the field to address the questions of uncertainty for the future.
 

 

With an exceptional speaker line-up including:
,
 
 
·         Dr Deborah Williams, Director, Government Affairs and Public Policy, Baxter
·         Dr Slawomir Chomik, Area Director, Central Europe, Solvay
·         Dr Marta Wielondek, Brand Director, Hemostaseology, Novartis
·         Susana Murteira, Head, Pricing & Reimbursement, Lundbeck
·         Prof Fabrizio Gianfrate, Health Economics, University of Ferrara
·         Dr Janice Haigh, Director, European Price and Trade, Astellas
 

 

expect to hear the latest on European pricing policy and strategy, market analyses and the impact of healthcare bodies on European P&R.
 

 

 

Who should attend:
 

 

Directors, Heads and Managers of:

 
  • Pricing and Reimbursement
  • Strategic Pricing
  • Marketing/Commercial Pricing
  • Price Monitoring
  • Reimbursement & Access
  • Health Economics
  • Economic Affairs
  • Outcomes Research
  • Corporate/Regulatory/Government Affairs
  • Pharmaceutical Policy
  • Advisor/Analyst
  • Brand Management
  • Sales & Marketing
  • Business Development
 

 

Benefits of attending:
 
  • Optimise your pricing and reimbursement strategy
  • Discover the impact of parallel trade and generics
  • Analyze how health economics and outcomes research can help to predict pricing issues
  • Identify regional variations in pricing and reimbursement across Europe
  • Understand how the market influences, and is influenced, by pharmaceutical pricing

Delegates from the following organisations have registered to attend:

 
  • Sanofi Aventis
  • Popewood Head and associates
  • Elan Drug Delivery
  • Alcon Laboratories (U K) Ltd
  • LFB Biomedicaments
  • ALMIRALL
  • The Medicines Company
  • Lundbeck
  • Teijin Pharma Limited
  • Glaxosmithkline Gmb H & Co K G
  • Novo Nordisk
  • Berlin-Chemie Menarini Group
  • Stiefel Laboratories Inc
  • GSK
  • Kyowa Hakko Kirin UK Ltd
  • Nycomed
  • APM Health Europe
  • Fresenius Medical Care GmbH
  • Biogen IDEC International GmbH
  • Novartis Pharma AG
  • Lloyds Pharmacy
  • Orion Pharma
  • Genzyme Corporation
  • Swedish Orphan A B
  • MME LLC
 

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Colin Wight

Colin Wight, Chief Executive, Galbraith Wight Limited

9:10 THE MOST COMMON PITFALLS IN PHARMACEUTICAL PRICING

Stephen Carter

Stephen Carter, Vice President, Pricing and Reimbursement Practice, Campbell Alliance

  • Review the most common mistakes made by pricing professionals and offer real world examples to further illustrate them.
  • Discuss common limitations that exist in the way that many companies approach pricing.  
  • Provide insights regarding how decision makers can avoid these limitations.
  • 10:30 Morning Coffee

    11:00 PRICING AND REIMBURSEMENT ISSUES WITH ORPHAN DRUGS IN EUROPE

    Don MacArthur

    Don MacArthur, Independent Consultant, Don MacArthur

  • What are orphan drugs and what does orphan designation offer?
  • Concerns of payers.
  • Funding and market access situation across EU.
  • Product case studies.
  • Can orphan drugs be cost-effective?
  • 11:40 SPAIN: PRICING AND REIMBURSEMENT POLICIES AND OUTLOOK

    Salome de Cambra

    Salome de Cambra, Senior Consultant, Pricing and Reimbursement Europe, RTI Health Solutions

  • Pricing policies, reimbursement processes and cost containment measures
  • Role of the autonomous regions
  • The emerging role health technology assessment
  • Outlook and implications for future P&R initiatives in Spain
  • 12:20 Networking Lunch

    13:50 RISK-SHARING AGREEMENTS AS A STRATEGIC TOOL FOR REIMBURSEMENT

    Colin Wight

    Colin Wight, Chief Executive, Galbraith Wight Limited

  • Value based/risk sharing contracts
  • Quantifying risk as an actual or contingent liability and negotiating agreements
  • Current limitations to risk-sharing agreements
  • Examples of risk-sharing agreements 
  • 14:30 WHAT EUROPE HAS TO TELL THE US ABOUT COMPARATIVE EFFECTIVENESS

    Deborah Williams

    Deborah Williams, Director, Government Affairs and Public Policy, Baxter Healthcare

  • US: Evaluating a new national institute for comparative effectiveness
  • Europe has over 20 years of experience in technology assessment
  • Where are the pitfalls? What issues around transparency proved to be important?
  • What is the role for patients? Who should define the questions?
  • What about commercial confidentiality of the data?
  • 15:10 INTEGRATING EUROPEAN P&R PRESPECTIVES IN THE DEVELOPMENT OF A GLOBAL PRICING STRATEGY

    Susana Murteira

    Susana Murteira, Head, Lundbeck

  • European P&R optimization - issues and oportunities for a global stategy
  • Maximizing Market Access - lessons from European context
  • Example
  • 15:50 Chairman’s Closing Remarks and Close of Day One

    16:00 Afternoon Tea

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Deborah Williams

    Deborah Williams, Director, Government Affairs and Public Policy, Baxter Healthcare

    9:10 REIMBURSEMENT CHALLENGES FOR CUTTING EDGE PRODUCTS

    Jenifer Ehreth

    Jenifer Ehreth, Vice President, The Medicines Company

  • Economic assessment of orphan indications
  • Biotech products that have no comparators
  • Where the price is an issue:  Small companies with small products
  • Economics versus equity

  • 9:50 EFFECTIVE P&R STRATEGIES IN EUROPE

    Colin Wight

    Colin Wight, Chief Executive, Galbraith Wight Limited

  • Developing trends in pricing models
  • Impacts for industry and payers
  • Factors affecting success of a strategy
  • 10:30 Morning Coffee

    11:00 PRICING OF LATE STAGE LCM PRODUCTS

    Marta Wielondek

    Marta Wielondek, Brand Director, Hemostaseology, Novartis Pharma

  • OTC -> premium pricing as sales strategy
  • Rx -> proactive Sick Fund Contracting
  • 11:40 THE NEW PRICING AND REIMBURSEMENT POLICY IN ITALY

    Fabrizio Gianfrate

    Fabrizio Gianfrate, Professor of Health Economics, University of Ferrara

  • Pricing policies, reimbursement processes and critical cost containment measures
  • The increased regional control and policies
  • The role of the Italian Medicines Agency (AIFA)
  • Future prospects and forecasts
  • 12:20 Networking Lunch

    13:50 PANEL DISCUSSION: GLOBAL PRICING PRESSURES IN TODAY’S ECONOMY

    Deborah Williams

    Deborah Williams, Director, Government Affairs and Public Policy, Baxter Healthcare

    Jenifer Ehreth

    Jenifer Ehreth, Vice President, The Medicines Company

    14:30 FORECASTING MARKET GROWTH – POSSIBILITIES CENTRAL EASTERN EUROPE P&R/REFORMS

    Slawomir Chomik

    Slawomir Chomik, Area Director Central Europe, Solvay

  • Current P&R strategies in Central Eastern Europe
  • Structure of the pharmaceutical market across Central Eastern Europe
  • Developing strategies to suit the market
  • Case study: selected country
  • 15:10 Afternoon Tea

    15:40 THE IMPACT OF PARALLEL TRADE ON PRICING STRATEGY

  • Should the impact of parallel trade be considered as part of pricing strategy?
  • What are the key issues?
  • New developments in European parallel trade
  • What are the tactical options for pricing managers?
  • Janice Haigh

    Janice Haigh, Senior Director Europe Price & Trade , Astellas Pharma Europe

    16:20 LEGAL ASPECTS OF PARALLEL TRADE

    Duncan Curley

    Duncan Curley , Director, Innovate Legal

    17:00 Chairman’s Closing Remarks and Close of Conference

    +

    The Charles Hotel

    Sophienstrasse 28
    Munich 80333
    Germany

    The Charles Hotel

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.